跳至主要内容
临床试验/NCT02266758
NCT02266758进行中(未招募)不适用

Comparing Two Gestational Diabetes Screening Methods: A Pragmatic Outpatient RCT

Kaiser Permanente0 个研究点目标入组 23,792 人开始时间: 2014年6月3日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
23,792
主要终点
Number of Newborns with Large for Gestational Age (LGA) Birthweight

研究概览

简要总结

This project randomizes two different screening strategies for diabetes in pregnancy, among a study population of over 17,500 pregnant women and their babies (over 35,000 total) in a large diverse health maintenance organization (HMO), to determine how diagnosis and treatment based on these two strategies in routine clinical care affects complications for the baby and the mother.

详细描述

Two recent randomized placebo-controlled trials show that gestational diabetes (GDM) treatment (vs. none) improves maternal and perinatal outcomes, based on diagnosis with a 2- step screening strategy. Also, a large multi-center prospective cohort study showed a linear relationship with glucose and maternal and perinatal outcomes, based on screening with a single 75g oral glucose tolerance test (OGTT). Based on this large cohort's findings, the American Diabetes Association recommended that clinical practice adopt the 1-step 75g screening approach for diagnosing GDM. The American College of Obstetrics & Gynecology took the opposite stance, recommending the traditional 2-step screening: because it alone has RCT outcome evidence. What is urgently needed to best inform clinical practice and health policy is not an additional GDM treatment vs. control trial, but a pragmatic randomized controlled trial (RCT) testing the 2 recommended clinical strategies. To pragmatically address this critical research gap, we propose to randomize an estimated 17,626 diverse women to GDM screening (2-step vs. 75g OGTT) as part of their clinical care in the Kaiser Permanente Northwest (KPNW) and Hawaii (KPH) regional health plans. The investigators will use the plans' electronic medical record (EMR) system at the time of GDM screening to randomize the women. Both KPNW and KPH regions universally screen for GDM at 24-28 weeks gestation, as part of clinical care. By randomizing GDM screening in the context of clinical care, the investigators will: Compare GDM prevalences (Aim 1) and differences in maternal and perinatal outcomes between screening strategies (Aim 2). Determine the concordance of the 75g OGTT with GDM diagnosed by 2-step, among a recruited sub-sample of 1,000 pregnant women at KPNW and KPH (Aim 3). The results of this pragmatic RCT are expected to help resolve the current public policy debate on the potential benefits and risks of each strategy in clinical obstetric practice.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • pregnant adult women in KPNW and KPH

排除标准

  • pre-existing diabetes

结局指标

主要结局

Number of Newborns with Large for Gestational Age (LGA) Birthweight

时间窗: Birth

Birthweight \> 90th percentile

Number of pregnant women with Gestational Hypertension & Pre-Eclampsia

时间窗: During Pregnancy to Delivery, up to 10 months

Based on International Classification of Diseases (ICD-10) diagnoses

Number of Pregnancies with GDM diagnosis

时间窗: During Pregnancy to Delivery, up to 10 months

Diagnosis of GDM based on laboratory values for each screening approach (1-step or 2-step) as planned in the original protocol.

Number of Cesarean Section Deliveries

时间窗: During Pregnancy to Delivery, up to 10 months

Primary Cesarean Section

Number of neonates with any component of a composite perinatal outcome

时间窗: Birth to first year of life

Includes any of the following: number of neonatal deaths, stillbirths, shoulder dystocia, bone fracture, or nerve palsy

次要结局

  • Number of stillbirths(During Pregnancy to Delivery)
  • Number of Pregnant Women with GDM Requiring Treatment(During Pregnancy to Delivery, up to 10 months)
  • Neonatal respiratory distress(Birth to first year of life)
  • Neonatal jaundice requiring treatment(Birth to first year of life)
  • Neonatal hypoglycemia(Birth to first year of life)
  • Birthweight(Birth)
  • Number of Neonatal Deaths(First week of life)
  • Number of Infants with Shoulder Dystocia(Birth to first year of life)
  • Number of Infant Bone Fractures or Nerve Palsies associated with delivery(Birth to first year of life)

研究者

申办方类型
Other
责任方
Sponsor

相似试验